Hemostasis Today

August, 2026
August 2026
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Christopher Cannon: Anticoagulation Shows Benefits Even in Low Risk Atrial Fibrillation Patients
Aug 29, 2026, 15:44

Christopher Cannon: Anticoagulation Shows Benefits Even in Low Risk Atrial Fibrillation Patients

Christopher Cannon, Cardiovascular Division at Brigham and Women’s Hospital, shared a post on LinkedIn about a recent article by Daehoon Kim et al, published in The New England Journal of Medicine, adding:

“Single AF benefit of anticoagulation is present in those with CHADs-2Vasc score of 1 (or 2 in women).

Similar 2 out of 3 reduction in stroke and overall CV events (as seen in other trials of higher risk patients) and no increase in bleeding.

Very important trial. Subgroup of AVVEROES had shown this as well but was just a small subgroup.

Now we can more clearly guide patients toward the benefit of anticoagulation even with low number of risk factors.”

Title: Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk

Authors: Daehoon Kim, Young Soo Lee, Jaemin Shim, Hee Tae Yu, Junbeom Park, Jin-Kyu Park, Il Young Oh, Ki-Woon Kang, Eue-Keun Choi, Kyoung-Min Park, Hyoung-Seob Park, Dae-Hyeok Kim, Hyung Wook Park, Jun Kim, Jum-Suk Ko, Dongmin Kim, Jong-Youn Kim, Jin-Bae Kim, Jung-Hoon Sung, Tae-Hoon Kim, Jae-Sun Uhm, Hui-Nam Pak, Boyoung Joung

Christopher Cannon: Anticoagulation Shows Benefits Even in Low Risk Atrial Fibrillation Patients

Stay updated on all scientific advances with Hemostasis Today.